Dynavax Technologies is a biopharmaceutical company dedicated to developing and commercializing novel vaccines and immuno-oncology therapeutics to address unmet medical needs. With a focus on leveraging the body's innate and adaptive immune responses, Dynavax aims to provide innovative solutions for a range of diseases, including infectious diseases and cancer.

Vice President, Chief Accounting Officer

ERP Manager

Associate Director, Benefits and Leaves of Absence

Director of Accounting and Finance

Benefits Manager for US Employee Programs

Director of Compensation and Benefits

IDN Key Account Executive II - South Ohio

<div><span style="font-size: 16px">This position can be 100% remote, but must be located in the United States.</span></div><div><span style="font-size: 16px">&nbsp;</span></div><div><span style="font-size: 16px">Dynavax is a commercial-stage biopharmaceutical company developing and commercializing novel vaccines to help protect the world against infectious diseases. We operate with the highest level of quality, integrity and safety for the betterment of public health. Our proprietary CpG 1018 adjuvant powers our diversified infectious vaccine portfolio, which includes HEPLISAV-B®, our commercial product approved in the U.S. and the European Union, for prevention of hepatitis B virus in adults. We also supply CpG 1018 to research collaborations and partnerships globally. Currently, CpG 1018 is being used in development of COVID-19, plague, shingles, and Tdap vaccines. </span></div><div><span style="font-size: 16px">&nbsp;</span></div><div><span style="font-size: 16px">At Dynavax, our vision and work ethic are guided by the collective ideals underpinning our core values, and these form the basis of our dynamic company culture. We strive to maintain a culture where each employee is valued by the organization and where our organization is valued by each employee. We offer a highly flexible work environment for our headquarter employees where individuals work remotely and gather for in-person meetings when necessary.&nbsp; Dynavax is headquartered in the San Francisco Bay area, and our manufacturing facility is in Düsseldorf, Germany.</span></div><div><br></div><div><span style="font-size: 16px;">This role is responsible for managing the preparation, quality control, publishing, dispatch, and archival of all regulatory submissions within the Veeva RIM system, ensuring compliance with regulations, SOPs, and internal standards. The Manager of Regulatory Operations will support Regulatory staff in coordinating and processing electronic regulatory filings across internal and external sources including but not limited to CMC, labeling, clinical, administrative, pharmacovigilance, and/or advertising and promotional material submissions. </span></div><div><span style="font-size: 16px;">&nbsp;</span></div><div><span style="font-size: 16px;">The Manager of Regulatory Operations oversees the regulatory submission process for all assigned projects and products throughout their lifecycle. This individual provides critical support to the Regulatory Department to facilitate efficient and compliant business practices. Additionally, the role is responsible for implementing and maintaining effective Veeva RIM and publishing systems, ensuring submissions adhere to established quality standards.</span></div>

Manager, Regulatory Operations

<div><span style="font-size: 16px">This position can be 100% remote, but must be located in the United States.</span></div><div><span style="font-size: 16px">&nbsp;</span></div><div><span style="font-size: 16px">Dynavax is a commercial-stage biopharmaceutical company developing and commercializing novel vaccines to help protect the world against infectious diseases. We operate with the highest level of quality, integrity and safety for the betterment of public health. Our proprietary CpG 1018 adjuvant powers our diversified infectious vaccine portfolio, which includes HEPLISAV-B®, our commercial product approved in the U.S. and the European Union, for prevention of hepatitis B virus in adults. We also supply CpG 1018 to research collaborations and partnerships globally. Currently, CpG 1018 is being used in development of COVID-19, plague, shingles, and Tdap vaccines. </span></div><div><span style="font-size: 16px">&nbsp;</span></div><div><span style="font-size: 16px">At Dynavax, our vision and work ethic are guided by the collective ideals underpinning our core values, and these form the basis of our dynamic company culture. We strive to maintain a culture where each employee is valued by the organization and where our organization is valued by each employee. We offer a highly flexible work environment for our headquarter employees where individuals work remotely and gather for in-person meetings when necessary.&nbsp; Dynavax is headquartered in the San Francisco Bay area, and our manufacturing facility is in Düsseldorf, Germany.</span></div><div><br></div><div><span style="font-size: 16px;">We are seeking an experienced Senior Director of Data and AI Architecture to lead our strategic data architecture initiatives across the Dynavax enterprise. This role will be instrumental in designing and implementing a robust data ecosystem that supports business-wide processes, with a focus on Data and AI enablement, and digital transformation. They will play a key role in our strategic cloud migration initiative, helping transform our enterprise data architecture into a modern, cloud-native ecosystem.</span></div>

Senior Director, Data and AI Architecture Leader

<div><span style="font-size: 16px">This position can be 100% remote, but must be located in the United States.</span></div><div><span style="font-size: 16px">&nbsp;</span></div><div><span style="font-size: 16px">Dynavax is a commercial-stage biopharmaceutical company developing and commercializing novel vaccines to help protect the world against infectious diseases. We operate with the highest level of quality, integrity and safety for the betterment of public health. Our proprietary CpG 1018 adjuvant powers our diversified infectious vaccine portfolio, which includes HEPLISAV-B®, our commercial product approved in the U.S. and the European Union, for prevention of hepatitis B virus in adults. We also supply CpG 1018 to research collaborations and partnerships globally. Currently, CpG 1018 is being used in development of COVID-19, plague, shingles, and Tdap vaccines. </span></div><div><span style="font-size: 16px">&nbsp;</span></div><div><span style="font-size: 16px">At Dynavax, our vision and work ethic are guided by the collective ideals underpinning our core values, and these form the basis of our dynamic company culture. We strive to maintain a culture where each employee is valued by the organization and where our organization is valued by each employee. We offer a highly flexible work environment for our headquarter employees where individuals work remotely and gather for in-person meetings when necessary.&nbsp; Dynavax is headquartered in the San Francisco Bay area, and our manufacturing facility is in Düsseldorf, Germany.</span></div><div><br></div><div><span style="font-size: 16px;">The Director, Drug Substance, Process Development and Manufacturing Sciences, will work closely with the Vice President, Process Development and Manufacturing Sciences, on the development and deployment of the technical operations strategy for Dynavax.&nbsp; This position will be responsible for providing oversight and leadership to drive CMC initiatives and activities related to drug substance process development. This role will be a recognized expert in managing the technical, logistical and operational aspects of assigned projects and/or processes from initiation thorough commercialization. This position also requires in-depth interactions with technical experts, researchers, regulatory affairs and clinical teams from various functions and external partners.</span></div>

Director, Drug Substance, Process Development & Manufacturing Sciences

<div>Dynavax is a commercial-stage biopharmaceutical company developing and commercializing novel vaccines to help protect the world against infectious diseases. We operate with the highest level of quality, integrity and safety for the betterment of public health. Our proprietary CpG 1018 adjuvant powers our diversified infectious vaccine portfolio, which includes HEPLISAV-B®, our commercial product approved in the U.S. and the European Union, for prevention of hepatitis B virus in adults. We also supply CpG 1018 to research collaborations and partnerships globally. Currently, CpG 1018 is being used in development of COVID-19, plague, shingles, and Tdap vaccines.&nbsp;</div><div>&nbsp;</div><div>At Dynavax, our vision and work ethic are guided by the collective ideals underpinning our core values, and these form the basis of our dynamic company culture. We strive to maintain a culture where each employee is valued by the organization and where our organization is valued by each employee. We offer a highly flexible work environment for our headquarter employees where individuals work remotely and gather for in-person meetings when necessary.&nbsp; Dynavax is headquartered in the San Francisco Bay area, and our manufacturing facility is in Düsseldorf, Germany.&nbsp;&nbsp;</div><div><br></div><div><span style="font-size: 16px;">The Retail Key Account Executive II will have full account responsibility and business ownership for assigned Retail Pharmacy Account(s) to establish and grow HEPLISAV-B sales. &nbsp;This position will be focused on establishing effective working relationships with designated leaders across designated retail banners.&nbsp; The Retail Key Account Executive II is responsible for complete vertical ownership of assigned field-based Division/Region/District leaders for designated retail pharmacy banner(s).&nbsp; In addition, the Retail Key Account Executive II will work directly with the National Account Directors to provide pull through support for National initiatives within designated Retail Pharmacy Banners. Candidates selected for the Retail Key Account Executive II position will be expected to execute all functions of the role independently with minimal supervision from the Director, Vaccine Sales and/or assigned mentor for executive level customer engagements.&nbsp; This position is field based and will require 60% travel. </span><i><b style="font-size: 16px;">The ideal candidate should reside in or near Indianapolis, IN, Cincinnati, OH, or Columbus, OH, but other locations in major metropolitan areas within the assigned territory will be considered.</b></i></div>

Retail Key Account Executive II – Great Lakes

<div><span style="font-size: 16px">This position can be 100% remote, but must be located in the United States.</span></div><div><span style="font-size: 16px">&nbsp;</span></div><div><span style="font-size: 16px">Dynavax is a commercial-stage biopharmaceutical company developing and commercializing novel vaccines to help protect the world against infectious diseases. We operate with the highest level of quality, integrity and safety for the betterment of public health. Our proprietary CpG 1018 adjuvant powers our diversified infectious vaccine portfolio, which includes HEPLISAV-B®, our commercial product approved in the U.S. and the European Union, for prevention of hepatitis B virus in adults. We also supply CpG 1018 to research collaborations and partnerships globally. Currently, CpG 1018 is being used in development of COVID-19, plague, shingles, and Tdap vaccines. </span></div><div><span style="font-size: 16px">&nbsp;</span></div><div><span style="font-size: 16px">At Dynavax, our vision and work ethic are guided by the collective ideals underpinning our core values, and these form the basis of our dynamic company culture. We strive to maintain a culture where each employee is valued by the organization and where our organization is valued by each employee. We offer a highly flexible work environment for our headquarter employees where individuals work remotely and gather for in-person meetings when necessary.&nbsp; Dynavax is headquartered in the San Francisco Bay area, and our manufacturing facility is in Düsseldorf, Germany.</span></div><div><br></div><div><span style="font-size: 16px;">The Clinical Trial Associate (CTA) II is responsible for the coordination of clinical operations activities. The CTA II will interact with the Dynavax Clinical Operations and the cross functional team; collaborate effectively with CROs, consultants, vendors, and clinical trial sites; and assure adherence to Good Clinical Practices, investigator integrity and compliance with all study procedures.</span></div><div><br></div><div><span style="font-size: 16px;">The CTA II facilitates the timely conduct of clinical studies according to protocols, Good Clinical Practice (GCP), Standard Operating Procedures (SOPs), and all applicable regulations governing the conduct of clinical trials. The scope of this position requires excellent organizational and communication skills.</span></div>

Clinical Trial Associate II (Contractor)

<div><span style="font-size: 16px">This position can be 100% remote, but must be located in the United States.</span></div><div><span style="font-size: 16px">&nbsp;</span></div><div><span style="font-size: 16px">Dynavax is a commercial-stage biopharmaceutical company developing and commercializing novel vaccines to help protect the world against infectious diseases. We operate with the highest level of quality, integrity and safety for the betterment of public health. Our proprietary CpG 1018 adjuvant powers our diversified infectious vaccine portfolio, which includes HEPLISAV-B®, our commercial product approved in the U.S. and the European Union, for prevention of hepatitis B virus in adults. We also supply CpG 1018 to research collaborations and partnerships globally. Currently, CpG 1018 is being used in development of COVID-19, plague, shingles, and Tdap vaccines. </span></div><div><span style="font-size: 16px">&nbsp;</span></div><div><span style="font-size: 16px">At Dynavax, our vision and work ethic are guided by the collective ideals underpinning our core values, and these form the basis of our dynamic company culture. We strive to maintain a culture where each employee is valued by the organization and where our organization is valued by each employee. We offer a highly flexible work environment for our headquarter employees where individuals work remotely and gather for in-person meetings when necessary.&nbsp; Dynavax is headquartered in the San Francisco Bay area, and our manufacturing facility is in Düsseldorf, Germany.</span></div><div><br></div><div><span style="font-size: 16px;">The Director, Clinical Supplies is responsible for ensuring investigational medicinal product (IMP) is delivered on time and in alignment with clinical and project plans. This includes oversight of planning, forecasting, sourcing, packaging, labeling, distribution, and return of clinical materials for clinical studies and investigator-initiated research (IIR).</span></div><div><br></div><div><span style="font-size: 16px;">This role is a key contributor to clinical development projects and works closely with cross-functional study teams, including Project Management, Technical Operations, Chemistry, Manufacturing and Controls (CMC), Clinical Operations, Regulatory Affairs and Quality.</span></div>

Director, Clinical Supplies

<div><span style="font-size: 16px">This position can be 100% remote, but must be located in the United States.</span></div><div><span style="font-size: 16px">&nbsp;</span></div><div><span style="font-size: 16px">Dynavax is a commercial-stage biopharmaceutical company developing and commercializing novel vaccines to help protect the world against infectious diseases. We operate with the highest level of quality, integrity and safety for the betterment of public health. Our proprietary CpG 1018 adjuvant powers our diversified infectious vaccine portfolio, which includes HEPLISAV-B®, our commercial product approved in the U.S. and the European Union, for prevention of hepatitis B virus in adults. We also supply CpG 1018 to research collaborations and partnerships globally. Currently, CpG 1018 is being used in development of COVID-19, plague, shingles, and Tdap vaccines. </span></div><div><span style="font-size: 16px">&nbsp;</span></div><div><span style="font-size: 16px">At Dynavax, our vision and work ethic are guided by the collective ideals underpinning our core values, and these form the basis of our dynamic company culture. We strive to maintain a culture where each employee is valued by the organization and where our organization is valued by each employee. We offer a highly flexible work environment for our headquarter employees where individuals work remotely and gather for in-person meetings when necessary.&nbsp; Dynavax is headquartered in the San Francisco Bay area, and our manufacturing facility is in Düsseldorf, Germany.</span></div><div><br></div><div><span style="font-size: 16px;">Under the direction of the clinical operations management, the Clinical Research Associate II will help to execute assigned clinical studies and ensure studies are completed on time, within budget, and in compliance with Good Clinical Practice (GCP), government regulations, SOPs and overall clinical objectives.</span></div>

Clinical Research Associate II (Contractor)

<div><span style="font-size: 16px;">The Senior Director, Regulatory Affairs position provides regulatory oversight for multiple projects focused on non-clinical and clinical aspects of drug development and associated regulations. This leadership role collaborates within Regulatory as well as with functional counterparts to ensure a global regulatory strategy is created and executed for all assigned projects. The role will also align with senior leadership on each proposed project regulatory strategy. In addition, this role will also serve as the internal Regulatory leader for other region activities (e.g., EU/UK filings, global partnerships, ex-US clinical trial applications), including collaborating with external counterparts as needed. This position will support all regulatory activities across the company’s overall regulatory strategy, spanning preclinical to Phase 4 product development, including marketed product activities. </span></div><div><span style="font-size: 16px;">&nbsp;</span></div><div><span style="font-size: 16px;">This position is also responsible for developing and implementing regulatory strategies for assigned products based on regulations, guidance, precedents and regulatory landscape, include but not limited to, developing relationships with the FDA contacts, leading FDA engagement strategies and execution, leading submissions to the INDs and BLA, tracking commitments and submission requirements. This role will partner with cross-functional subject matter experts to develop a CCDS / country label prior to Phase 3 to support the path to registration and partner with functional leads to drive development of (s)BLA strategy for registration of assigned programs. Duties related to ex-US activities include coordination of submission requirements and regulatory engagement strategies in collaboration with external resources. Additional responsibilities related to strategic initiatives, due diligence, and policy development will be assigned on an as needed basis.</span></div>

Senior Director, Regulatory Affairs

<div><span style="font-size: 16px">This position can be 100% remote, but must be located in the United States.</span></div><div><span style="font-size: 16px">&nbsp;</span></div><div><span style="font-size: 16px">Dynavax is a commercial-stage biopharmaceutical company developing and commercializing novel vaccines to help protect the world against infectious diseases. We operate with the highest level of quality, integrity and safety for the betterment of public health. Our proprietary CpG 1018 adjuvant powers our diversified infectious vaccine portfolio, which includes HEPLISAV-B®, our commercial product approved in the U.S. and the European Union, for prevention of hepatitis B virus in adults. We also supply CpG 1018 to research collaborations and partnerships globally. Currently, CpG 1018 is being used in development of COVID-19, plague, shingles, and Tdap vaccines. </span></div><div><span style="font-size: 16px">&nbsp;</span></div><div><span style="font-size: 16px">At Dynavax, our vision and work ethic are guided by the collective ideals underpinning our core values, and these form the basis of our dynamic company culture. We strive to maintain a culture where each employee is valued by the organization and where our organization is valued by each employee. We offer a highly flexible work environment for our headquarter employees where individuals work remotely and gather for in-person meetings when necessary.&nbsp; Dynavax is headquartered in the San Francisco Bay area, and our manufacturing facility is in Düsseldorf, Germany.</span></div><div><br></div><div><span style="font-size: 16px;">The Senior Director, Retail Marketing and Operations will lead the development and implementation of retail marketing initiatives to support the commercialization of our products and manage marketing operations for HEPLISAV-B®. This position is responsible for planning and implementing impactful initiatives, and involves bringing strategic insights and effective leadership to drive the overall success of the product portfolio.&nbsp;</span></div>

Senior Director, Retail Marketing and Operations

<div>Dynavax is a commercial-stage biopharmaceutical company developing and commercializing novel vaccines to help protect the world against infectious diseases. We operate with the highest level of quality, integrity and safety for the betterment of public health. Our proprietary CpG 1018 adjuvant powers our diversified infectious vaccine portfolio, which includes HEPLISAV-B®, our commercial product approved in the U.S. and the European Union, for prevention of hepatitis B virus in adults. We also supply CpG 1018 to research collaborations and partnerships globally. Currently, CpG 1018 is being used in development of COVID-19, plague, shingles, and Tdap vaccines.&nbsp;</div><div>&nbsp;</div><div>At Dynavax, our vision and work ethic are guided by the collective ideals underpinning our core values, and these form the basis of our dynamic company culture. We strive to maintain a culture where each employee is valued by the organization and where our organization is valued by each employee. We offer a highly flexible work environment for our headquarter employees where individuals work remotely and gather for in-person meetings when necessary.&nbsp; Dynavax is headquartered in the San Francisco Bay area, and our manufacturing facility is in Düsseldorf, Germany.&nbsp;&nbsp;</div><div><br></div><div><span style="font-size: 16px;">The IDN Key Account Executive II will have full account responsibility and business ownership for assigned Accounts to establish and grow HEPLISAV-B sales. &nbsp;Working with the Director, Vaccine Sales this position will serve as the primary account owner with assigned IDN, Independent and Group Practice accounts.&nbsp; The IDN Key Account Executive II will be responsible for full top down and bottom up ownership and execution in assigned accounts with a primary objective of expanding Adult Hepatitis B Vaccination and greater adoption of HEPLISAV-B.&nbsp; This role will be responsible for understanding sales strategies and execution plans that enable HEPLISAV-B to meet its full revenue potential in assigned accounts. The IDN Key Account Executive II position will be expected to execute all functions of the role independently with minimal supervision from the Director, Vaccine Sales and/or assigned mentor for executive level customer engagements.&nbsp; This position is field based and will require daily travel. </span><i><b style="font-size: 16px;">The ideal candidate should reside in or near Chicago, but other locations in major metropolitan areas within the assigned territory will be considered.</b></i></div>

IDN Key Account Executive II - Chicago, IL

<div>Dynavax is a commercial-stage biopharmaceutical company developing and commercializing novel vaccines to help protect the world against infectious diseases. We operate with the highest level of quality, integrity and safety for the betterment of public health. Our proprietary CpG 1018 adjuvant powers our diversified infectious vaccine portfolio, which includes HEPLISAV-B®, our commercial product approved in the U.S. and the European Union, for prevention of hepatitis B virus in adults. We also supply CpG 1018 to research collaborations and partnerships globally. Currently, CpG 1018 is being used in development of COVID-19, plague, shingles, and Tdap vaccines.&nbsp;</div><div>&nbsp;</div><div>At Dynavax, our vision and work ethic are guided by the collective ideals underpinning our core values, and these form the basis of our dynamic company culture. We strive to maintain a culture where each employee is valued by the organization and where our organization is valued by each employee. We offer a highly flexible work environment for our headquarter employees where individuals work remotely and gather for in-person meetings when necessary.&nbsp; Dynavax is headquartered in the San Francisco Bay area, and our manufacturing facility is in Düsseldorf, Germany.&nbsp;&nbsp;</div><div><br></div><div><span style="font-size: 16px;">The IDN Key Account Executive II will have full account responsibility and business ownership for assigned Accounts to establish and grow HEPLISAV-B sales. &nbsp;Working with the Director, Vaccine Sales this position will serve as the primary account owner with assigned IDN, Independent and Group Practice accounts.&nbsp; The IDN Key Account Executive II will be responsible for full top down and bottom up ownership and execution in assigned accounts with a primary objective of expanding Adult Hepatitis B Vaccination and greater adoption of HEPLISAV-B.&nbsp; This role will be responsible for understanding sales strategies and execution plans that enable HEPLISAV-B to meet its full revenue potential in assigned accounts. The IDN Key Account Executive II position will be expected to execute all functions of the role independently with minimal supervision from the Director, Vaccine Sales and/or assigned mentor for executive level customer engagements.&nbsp; This position is field based and will require daily travel. </span><b style="font-size: 16px;"><i>The ideal candidate should reside in or near Los Angeles, Riverside, or Orange County, but other locations in major metropolitan areas within the assigned territory will be considered.</i></b></div>

IDN Key Account Executive II - Los Angeles South, CA

<div>Dynavax is a commercial-stage biopharmaceutical company developing and commercializing novel vaccines to help protect the world against infectious diseases. We operate with the highest level of quality, integrity and safety for the betterment of public health. Our proprietary CpG 1018 adjuvant powers our diversified infectious vaccine portfolio, which includes HEPLISAV-B®, our commercial product approved in the U.S. and the European Union, for prevention of hepatitis B virus in adults. We also supply CpG 1018 to research collaborations and partnerships globally. Currently, CpG 1018 is being used in development of COVID-19, plague, shingles, and Tdap vaccines.&nbsp;</div><div>&nbsp;</div><div>At Dynavax, our vision and work ethic are guided by the collective ideals underpinning our core values, and these form the basis of our dynamic company culture. We strive to maintain a culture where each employee is valued by the organization and where our organization is valued by each employee. We offer a highly flexible work environment for our headquarter employees where individuals work remotely and gather for in-person meetings when necessary.&nbsp; Dynavax is headquartered in the San Francisco Bay area, and our manufacturing facility is in Düsseldorf, Germany.&nbsp;&nbsp;</div><div><br></div><div><span style="font-size: 16px;">The IDN Key Account Executive II will have full account responsibility and business ownership for assigned Accounts to establish and grow HEPLISAV-B sales. &nbsp;Working with the Director, Vaccine Sales this position will serve as the primary account owner with assigned IDN, Independent and Group Practice accounts.&nbsp; The IDN Key Account Executive II will be responsible for full top down and bottom up ownership and execution in assigned accounts with a primary objective of expanding Adult Hepatitis B Vaccination and greater adoption of HEPLISAV-B.&nbsp; This role will be responsible for understanding sales strategies and execution plans that enable HEPLISAV-B to meet its full revenue potential in assigned accounts. The IDN Key Account Executive II position will be expected to execute all functions of the role independently with minimal supervision from the Director, Vaccine Sales and/or assigned mentor for executive level customer engagements.&nbsp; This position is field based and will require daily travel. </span><i><b style="font-size: 16px;">The ideal candidate should reside in or near Pittsburgh, PA or Cleveland, OH, but other locations in major metropolitan areas within the assigned territory will be considered.</b></i></div>

IDN Key Account Executive II - Western PA/Northern OH

<div>Dynavax is a commercial-stage biopharmaceutical company developing and commercializing novel vaccines to help protect the world against infectious diseases. We operate with the highest level of quality, integrity and safety for the betterment of public health. Our proprietary CpG 1018 adjuvant powers our diversified infectious vaccine portfolio, which includes HEPLISAV-B®, our commercial product approved in the U.S. and the European Union, for prevention of hepatitis B virus in adults. We also supply CpG 1018 to research collaborations and partnerships globally. Currently, CpG 1018 is being used in development of COVID-19, plague, shingles, and Tdap vaccines.&nbsp;</div><div>&nbsp;</div><div>At Dynavax, our vision and work ethic are guided by the collective ideals underpinning our core values, and these form the basis of our dynamic company culture. We strive to maintain a culture where each employee is valued by the organization and where our organization is valued by each employee. We offer a highly flexible work environment for our headquarter employees where individuals work remotely and gather for in-person meetings when necessary.&nbsp; Dynavax is headquartered in the San Francisco Bay area, and our manufacturing facility is in Düsseldorf, Germany.&nbsp;&nbsp;</div><div><br></div><div><span style="font-size: 16px;">The Retail Key Account Executive II will have full account responsibility and business ownership for assigned Retail Pharmacy Account(s) to establish and grow HEPLISAV-B sales. &nbsp;This position will be focused on establishing effective working relationships with designated leaders across designated retail banners.&nbsp; The Retail Key Account Executive II is responsible for complete vertical ownership of assigned field-based Division/Region/District leaders for designated retail pharmacy banner(s).&nbsp; In addition, the Retail Key Account Executive II will work directly with the National Account Directors to provide pull through support for National initiatives within designated Retail Pharmacy Banners. Candidates selected for the Retail Key Account Executive II position will be expected to execute all functions of the role independently with minimal supervision from the Director, Vaccine Sales and/or assigned mentor for executive level customer engagements.&nbsp; This position is field based and will require 60% travel. </span><i><b style="font-size: 16px;">The ideal candidate should reside in or near Detroit, MI, Columbus, OH, Cleveland, OH, Louisville, KY, or Pittsburgh, PA, but other locations in major metropolitan areas within the assigned territory will be considered.</b></i></div>

IDN Key Account Executive II - South Ohio

Your career is worth investing in.

Get unlimited referrals with Premium.